Trial Details
COMPLETEDBasic Information
| Clinical ID | c1391 |
|---|---|
| Identifier | NCT02100696 |
| Trial Title | A Study of the Efficacy and Safety of Etrolizumab in Participants With Ulcerative Colitis Who Have Been Previously Exposed to Tumor Necrosis Factor (TNF) Inhibitors |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: Etrozulimab|DRUG: Placebo |
Participant Information
| Sponsor | Hoffmann-La Roche |
|---|---|
| City | Birmingham |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2014-05-21 |
|---|---|
| Primary Completion Date | 2020-04-16 |
| Completion Date | 2020-04-16 |